350 related articles for article (PubMed ID: 34016972)
21. Modulation of Innate Immune Signalling by Lipid-Mediated MAVS Transmembrane Domain Oligomerization.
Nobre L; Wise D; Ron D; Volmer R
PLoS One; 2015; 10(8):e0136883. PubMed ID: 26317833
[TBL] [Abstract][Full Text] [Related]
22. Sec13 is a positive regulator of VISA-mediated antiviral signaling.
Chen T; Wang D; Xie T; Xu LG
Virus Genes; 2018 Aug; 54(4):514-526. PubMed ID: 29948782
[TBL] [Abstract][Full Text] [Related]
23. DDIT3 Targets Innate Immunity via the DDIT3-OTUD1-MAVS Pathway To Promote Bovine Viral Diarrhea Virus Replication.
Wang S; Hou P; Pan W; He W; He DC; Wang H; He H
J Virol; 2021 Feb; 95(6):. PubMed ID: 33361422
[TBL] [Abstract][Full Text] [Related]
24. Negative regulation of RIG-I-mediated antiviral signaling by TRK-fused gene (TFG) protein.
Lee NR; Shin HB; Kim HI; Choi MS; Inn KS
Biochem Biophys Res Commun; 2013 Jul; 437(1):168-72. PubMed ID: 23810392
[TBL] [Abstract][Full Text] [Related]
25. DDX3 directly regulates TRAF3 ubiquitination and acts as a scaffold to co-ordinate assembly of signalling complexes downstream from MAVS.
Gu L; Fullam A; McCormack N; Höhn Y; Schröder M
Biochem J; 2017 Feb; 474(4):571-587. PubMed ID: 27980081
[TBL] [Abstract][Full Text] [Related]
26. TAX1BP1 Restrains Virus-Induced Apoptosis by Facilitating Itch-Mediated Degradation of the Mitochondrial Adaptor MAVS.
Choi YB; Shembade N; Parvatiyar K; Balachandran S; Harhaj EW
Mol Cell Biol; 2017 Jan; 37(1):. PubMed ID: 27736772
[TBL] [Abstract][Full Text] [Related]
27. Influenza M2 protein regulates MAVS-mediated signaling pathway through interacting with MAVS and increasing ROS production.
Wang R; Zhu Y; Lin X; Ren C; Zhao J; Wang F; Gao X; Xiao R; Zhao L; Chen H; Jin M; Ma W; Zhou H
Autophagy; 2019 Jul; 15(7):1163-1181. PubMed ID: 30741586
[TBL] [Abstract][Full Text] [Related]
28. Negative Regulation of RNF90 on RNA Virus-Triggered Antiviral Immune Responses Targeting MAVS.
Yang B; Zhang G; Qin X; Huang Y; Ren X; Sun J; Ma S; Liu Y; Song D; Liu Y; Cui Y; Wang H; Wang J
Front Immunol; 2021; 12():730483. PubMed ID: 34512666
[TBL] [Abstract][Full Text] [Related]
29. Control of antiviral innate immune response by protein geranylgeranylation.
Yang S; Harding AT; Sweeney C; Miao D; Swan G; Zhou C; Jiang Z; Fitzgerald KA; Hammer G; Bergo MO; Kroh HK; Lacy DB; Sun C; Glogauer M; Que LG; Heaton NS; Wang D
Sci Adv; 2019 May; 5(5):eaav7999. PubMed ID: 31149635
[TBL] [Abstract][Full Text] [Related]
30.
Seo J; Park YS; Kweon TH; Kang J; Son S; Kim HB; Seo YR; Kang MJ; Yi EC; Lee YH; Kim JH; Park B; Yang WH; Cho JW
Front Immunol; 2020; 11():589259. PubMed ID: 33603735
[TBL] [Abstract][Full Text] [Related]
31. MOV10 Provides Antiviral Activity against RNA Viruses by Enhancing RIG-I-MAVS-Independent IFN Induction.
Cuevas RA; Ghosh A; Wallerath C; Hornung V; Coyne CB; Sarkar SN
J Immunol; 2016 May; 196(9):3877-86. PubMed ID: 27016603
[TBL] [Abstract][Full Text] [Related]
32. Virus subtype-specific suppression of MAVS aggregation and activation by PB1-F2 protein of influenza A (H7N9) virus.
Cheung PH; Lee TT; Kew C; Chen H; Yuen KY; Chan CP; Jin DY
PLoS Pathog; 2020 Jun; 16(6):e1008611. PubMed ID: 32511263
[TBL] [Abstract][Full Text] [Related]
33. Ubiquitin-regulated recruitment of IkappaB kinase epsilon to the MAVS interferon signaling adapter.
Paz S; Vilasco M; Arguello M; Sun Q; Lacoste J; Nguyen TL; Zhao T; Shestakova EA; Zaari S; Bibeau-Poirier A; Servant MJ; Lin R; Meurs EF; Hiscott J
Mol Cell Biol; 2009 Jun; 29(12):3401-12. PubMed ID: 19380491
[TBL] [Abstract][Full Text] [Related]
34. Forkhead box O1-mediated ubiquitination suppresses RIG-I-mediated antiviral immune responses.
Ma Z; Zhang W; Fan W; Wu Y; Zhang M; Xu J; Li W; Sun L; Liu W; Liu W
Int Immunopharmacol; 2021 Jan; 90():107152. PubMed ID: 33187908
[TBL] [Abstract][Full Text] [Related]
35. The mitochondrial antiviral protein MAVS associates with NLRP3 and regulates its inflammasome activity.
Park S; Juliana C; Hong S; Datta P; Hwang I; Fernandes-Alnemri T; Yu JW; Alnemri ES
J Immunol; 2013 Oct; 191(8):4358-66. PubMed ID: 24048902
[TBL] [Abstract][Full Text] [Related]
36. PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4.
You F; Sun H; Zhou X; Sun W; Liang S; Zhai Z; Jiang Z
Nat Immunol; 2009 Dec; 10(12):1300-8. PubMed ID: 19881509
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide.
Xiao X; Fu Y; You W; Huang C; Zeng F; Gu X; Sun X; Li J; Zhang Q; Du W; Cheng G; Liu Z; Liu L
J Virol; 2024 May; 98(5):e0157323. PubMed ID: 38572974
[TBL] [Abstract][Full Text] [Related]
38. The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling.
Chiang C; Pauli EK; Biryukov J; Feister KF; Meng M; White EA; Münger K; Howley PM; Meyers C; Gack MU
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263274
[TBL] [Abstract][Full Text] [Related]
39. The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/MAVS signaling pathway by targeting TRAF3 for degradation.
Nakhaei P; Mesplede T; Solis M; Sun Q; Zhao T; Yang L; Chuang TH; Ware CF; Lin R; Hiscott J
PLoS Pathog; 2009 Nov; 5(11):e1000650. PubMed ID: 19893624
[TBL] [Abstract][Full Text] [Related]
40. NLRX1 Mediates MAVS Degradation To Attenuate the Hepatitis C Virus-Induced Innate Immune Response through PCBP2.
Qin Y; Xue B; Liu C; Wang X; Tian R; Xie Q; Guo M; Li G; Yang D; Zhu H
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
